Pharmaceutical PV DIV - FSB
Ended Awarded Last action
- Contract number
- SPE2DU26FEEFC
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $24,133
Award facts
- Contract value 100% obligated
- $24,132.70 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a delivery order valued at $24,132.70 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois. This firm fixed-price delivery order, awarded on January 12, 2026, with an ultimate completion date of January 13, 2026, was issued without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. The award represents one of numerous delivery orders issued to DMS Pharmaceutical Group under its Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) indefinite delivery contract, a $30.3 billion DLA acquisition strategy that authorizes the issuance of firm fixed-price orders for comprehensive pharmaceutical products and medical consumables to support Department of Defense healthcare operations.
DMS Pharmaceutical Group has been registered in the System for Award Management since July 2001 and supplies an extensive portfolio of branded and generic prescription medications, over-the-counter drugs, biologics, vaccines, and specialty pharmaceuticals to federal agencies. Under the PPV-G GEN V contract vehicle awarded in November 2025 with a $499,999,999 ceiling and completion date of December 31, 2036, the company serves as a regional prime vendor contractor positioned to fulfill diverse pharmaceutical requirements for military healthcare facilities worldwide. The contractor's established performance on numerous delivery orders and its status as a woman-owned small business underscore its role as a critical supplier within the federal pharmaceutical supply chain, with no subcontractor relationships identified in the award documentation.
Quick answers
Who was awarded contract SPE2DU26FEEFC?
SPE2DU26FEEFC was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 12, 2026.
How much is contract SPE2DU26FEEFC worth?
The government has obligated $24,133 on SPE2DU26FEEFC.
Is contract SPE2DU26FEEFC an order under another contract?
Yes. SPE2DU26FEEFC is a delivery order under SPE2DU25D9439, an indefinite delivery contract.
Was contract SPE2DU26FEEFC competed?
The extent of competition for SPE2DU26FEEFC was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award